PI(38:5) (BioDeep_00000604947)

   


代谢物信息卡片


1-(10Z,13Z,16Z-Docosatrienoyl)-2-(9Z,12Z-hexadecadienoate)-sn-glycero-3-phospho-(1-myo-inositol)

化学式: C47H81O13P (884.5414506)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES:
InChI:

描述信息

同义名列表

181 个代谢物同义名

1-(7Z,10Z,13Z,16Z,19Z-Docosapentaenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-(1-myo-inositol); 1-Docosapentaenoyl-2-palmitoyl-sn-glycero-3-phosphoinositol; PI(22:5(7Z,10Z,13Z,16Z,19Z)/16:0); Phosphatidylinositol(22:5n3/16:0); Phosphatidylinositol(22:5W3/16:0); Phosphatidylinositol(22:5/16:0); Phosphatidylinositol(38:5); Pino(22:5W3/16:0); Pino(22:5n3/16:0); Pino(22:5/16:0); PI(22:5W3/16:0); PI(22:5n3/16:0); PI(22:5/16:0); PIno(38:5); PI(38:5); 1-(4Z,7Z,10Z,13Z,16Z-Docosapentaenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-(1-myo-inositol); 1-Osbondoyl-2-palmitoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(22:5n6/16:0); Phosphatidylinositol(22:5W6/16:0); PI(22:5(4Z,7Z,10Z,13Z,16Z)/16:0); Pino(22:5W6/16:0); Pino(22:5n6/16:0); PI(22:5W6/16:0); PI(22:5n6/16:0); 1-(10Z,13Z,16Z-Docosatrienoyl)-2-(9Z,12Z-hexadecadienoate)-sn-glycero-3-phospho-(1-myo-inositol); 1-(10Z,13Z,16Z-Docosatrienoyl)-2-(9Z,12Z-hexadecadienoate)-sn-glycero-3-phosphoinositol; 1-(10Z,13Z,16Z-Docosatrienoyl)-2-(9Z,12Z-hexadecadienoic acid; 1-(10Z,13Z,16Z-Docosatrienoyl)-2-(9Z,12Z-hexadecadienoate; Phosphatidylinositol(22:3n6/16:2n4); Phosphatidylinositol(22:3w6/16:2w4); PI(22:3(10Z,13Z,16Z)/16:2(9Z,12Z)); Phosphatidylinositol(22:3/16:2); PIno(22:3w6/16:2w4); PIno(22:3n6/16:2n4); PI(22:3w6/16:2w4); PI(22:3n6/16:2n4); PIno(22:3/16:2); PI(22:3/16:2); 1-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-Arachidonoyl-2-oleoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(20:4n6/18:1n9); Phosphatidylinositol(20:4w6/18:1w9); PI(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)); Phosphatidylinositol(20:4/18:1); PIno(20:4w6/18:1w9); PIno(20:4n6/18:1n9); PI(20:4n6/18:1n9); PI(20:4w6/18:1w9); Pino(20:4/18:1); PI(20:4/18:1); 1-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-Arachidonoyl-2-vaccenoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(20:4W6/18:1W7); Phosphatidylinositol(20:4n6/18:1n7); PI(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)); Pino(20:4n6/18:1n7); Pino(20:4W6/18:1W7); PI(20:4W6/18:1W7); PI(20:4n6/18:1n7); 1-(8Z,11Z,14Z-Eicosatrienoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-homo-gamma-linolenoyl-2-linoleoyl-sn-glycero-3-phosphoinositol; 1-Homo-g-linolenoyl-2-linoleoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(20:3n6/18:2n6); Phosphatidylinositol(20:3w6/18:2w6); PI(20:3(8Z,11Z,14Z)/18:2(9Z,12Z)); Phosphatidylinositol(20:3/18:2); PIno(20:3n6/18:2n6); PIno(20:3w6/18:2w6); PI(20:3n6/18:2n6); PI(20:3w6/18:2w6); PIno(20:3/18:2); PI(20:3/18:2); 1-(5Z,8Z,11Z-eicosatrienoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-meadoyl-2-linoleoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(20:3w9/18:2w6); Phosphatidylinositol(20:3n9/18:2n6); PI(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)); PIno(20:3w9/18:2w6); PIno(20:3n9/18:2n6); PI(20:3w9/18:2w6); PI(20:3n9/18:2n6); 1-(9Z,12Z-Octadecadienoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-linoleoyl-2-homo-gamma-linolenoyl-sn-glycero-3-phosphoinositol; 1-Linoleoyl-2-homo-g-linolenoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(18:2w6/20:3w6); Phosphatidylinositol(18:2n6/20:3n6); PI(18:2(9Z,12Z)/20:3(8Z,11Z,14Z)); Phosphatidylinositol(18:2/20:3); PIno(18:2w6/20:3w6); PIno(18:2n6/20:3n6); PI(18:2n6/20:3n6); PI(18:2w6/20:3w6); PIno(18:2/20:3); PI(18:2/20:3); 1-(9Z,12Z-Octadecadienoyl)-2-(5Z,8Z,11Z-eicosatrienoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-Linoleoyl-2-meadoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(18:2n6/20:3n9); Phosphatidylinositol(18:2w6/20:3w9); PI(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)); PIno(18:2w6/20:3w9); PIno(18:2n6/20:3n9); PI(18:2n6/20:3n9); PI(18:2w6/20:3w9); 1-(9Z-Octadecenoyl)-2-(8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-Oleoyl-2-eicsoatetraenoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(18:1w9/20:4w3); Phosphatidylinositol(18:1n9/20:4n3); PI(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)); Phosphatidylinositol(18:1/20:4); 1-Oleoyl-2-eicsoic acid; PIno(18:1w9/20:4w3); 1-Oleoyl-2-eicsoate; PIno(18:1n9/20:4n3); PI(18:1n9/20:4n3); PI(18:1w9/20:4w3); PIno(18:1/20:4); PI(18:1/20:4); 1-(9Z-octadecenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-Oleoyl-2-arachidonoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(18:1W9/20:4W6); Phosphatidylinositol(18:1n9/20:4n6); PI(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)); PIno(18:1W9/20:4W6); PIno(18:1n9/20:4n6); PI(18:1n9/20:4n6); PI(18:1W9/20:4W6); 1-(11Z-Octadecenoyl)-2-(8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-Vaccenoyl-2-eicsoatetraenoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(18:1n7/20:4n3); Phosphatidylinositol(18:1w7/20:4w3); PI(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)); 1-Vaccenoyl-2-eicsoic acid; 1-Vaccenoyl-2-eicsoate; PIno(18:1w7/20:4w3); PIno(18:1n7/20:4n3); PI(18:1n7/20:4n3); PI(18:1w7/20:4w3); 1-(11Z-octadecenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-vaccenoyl-2-arachidonoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(18:1n7/20:4n6); Phosphatidylinositol(18:1w7/20:4w6); PI(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)); PIno(18:1n7/20:4n6); PIno(18:1w7/20:4w6); PI(18:1w7/20:4w6); PI(18:1n7/20:4n6); 1-(9Z,12Z-Hexadecadienoate)-2-(10Z,13Z,16Z-docosatrienoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-(9Z,12Z-Hexadecadienoate)-2-(10Z,13Z,16Z-docosatrienoyl)-sn-glycero-3-phosphoinositol; Phosphatidylinositol(16:2W4/22:3W6); Phosphatidylinositol(16:2n4/22:3n6); PI(16:2(9Z,12Z)/22:3(10Z,13Z,16Z)); Phosphatidylinositol(16:2/22:3); 1-(9Z,12Z-Hexadecadienoic acid; 1-(9Z,12Z-Hexadecadienoate; Pino(16:2W4/22:3W6); Pino(16:2n4/22:3n6); PI(16:2W4/22:3W6); PI(16:2n4/22:3n6); Pino(16:2/22:3); PI(16:2/22:3); 1-Hexadecanoyl-2-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-Palmitoyl-2-docosapentaenoyl-sn-glycero-3-phosphoinositol; PI(16:0/22:5(7Z,10Z,13Z,16Z,19Z)); Phosphatidylinositol(16:0/22:5n3); Phosphatidylinositol(16:0/22:5w3); Phosphatidylinositol(16:0/22:5); PIno(16:0/22:5w3); PIno(16:0/22:5n3); PI(16:0/22:5w3); PIno(16:0/22:5); PI(16:0/22:5n3); PI(16:0/22:5); 1-Hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3-phospho-(1-myo-inositol); 1-Palmitoyl-2-osbondoyl-sn-glycero-3-phosphoinositol; Phosphatidylinositol(16:0/22:5w6); Phosphatidylinositol(16:0/22:5n6); PI(16:0/22:5(4Z,7Z,10Z,13Z,16Z)); PIno(16:0/22:5n6); PIno(16:0/22:5w6); PI(16:0/22:5w6); PI(16:0/22:5n6)



数据库引用编号

17 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表